In CodeBreak 101 (NCT04185883), sotorasib is combined with afatinib or panitumumab, an anti-EGFR monoclonal antibody (with or without FOLFIRI),240 in patients with NSCLC. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.